China’s demand for OTC Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption...
Consumer health has seen slightly higher growth overall in current value terms in 2020 compared to the previous year. Nevertheless, growth has remained largely in line with the review period average, with economic pressures preventing any more significant gains. When COVID-19 first appeared in South Africa there was some initial stockpiling...
Consumer health is expected to see slightly higher current value growth in 2020 than was seen in 2019, with COVID-19 expected to be one of the main factors dictating growth in Uruguay. While the COVID-19 outbreak in Uruguay had little impact in terms of infections and deaths due to the country’s good healthcare system, locals’ concern about...
In response to COVID-19 the Swiss government introduced a range of measures to limit the spread of the virus, with this having a mixed impact on the various categories of consumer health. Nonetheless, there was an overall improvement seen in 2020, spurred on by stronger sales in key categories including analgesics, cough, cold and allergy...
COVID-19 had a significant impact on consumer health in Austria in 2020 with it resulting in consumers reassessing their priorities and focusing on their immediate concerns. As concerns rose about the threat posed by COVID-19 many households started stocking up on products that were perceived to treat the symptoms of the virus, such as analgesics...
2020 has proven to be a fairly turbulent year for consumer health in Germany following the emergence of the pandemic. After the ‘’hamster’’ (stockpiling purchases) period in March due to various lockdown restrictions by the government in an effort to curb the spread of the virus, it was followed by a slump, with the market subsequently entering...
The first cases of COVID-19 in Belarus were recorded on 27 February 2020 and, in June 2020, Belarus continued to record nearly 800 cases of COVID-19 daily. Stockpiling occurred in mid-March 2020, with COVID-19 driving demand for analgesics, cough, cold and allergy (hay fever) remedies, vitamins and dietary supplements. No quarantine took place...
COVID-19 will not have a significant impact on growth in current retail value sales of consumer health in Bosnia and Herzegovina during 2020. Neither stockpiling nor significant product shortages have been reported. Moreover, the income elasticity of demand for many consumer health products is quite low, so the economic slowdown provoked by...
Consumer health value sales will continue to grow in 2020, despite the negative economic impact of COVID-19 on the economy. Lower purchasing power among middle-income consumers and the rising cost of healthcare in Argentina have fuelled a shift towards self-medication in recent years, thus encouraging preventive healthcare. Following this...
Overall consumer health is not expected to see a significant difference in its growth rate in 2020 compared with the previous year, with just a marginally higher current value increase. However, the emergence of the COVID-19 virus in the country at the beginning of the year had different impacts on different consumer health categories. Consumer...